Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re: Nexium (Esomeprazole) Antitrust Litigation
Case Number:
1:12-md-02409
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Andrews DeValerio
- Baker & Hostetler
- Berger Montague
- Berman Tabacco
- Buchanan Ingersoll
- Carella Byrne
- Cohen Milstein
- Cohn Lifland
- Conn Kavanaugh
- Covington & Burling
- Douglas & London
- Dugan Law Firm
- Faruqi & Faruqi
- Fisher & Phillips
- Foley & Lardner
- FrancoLaw PLLC
- Garwin Gerstein
- Girard Sharp
- Glancy Prongay
- Goldman Scarlato
- Hach & Rose
- Hach Rose Schirripa
- Hagens Berman
- Hamilton Brook
- Hangley Aronchick
- Heim Payne
- Hilliard & Shadowen
- Jones Day
- Justice Law Collaborative
- Kirkland & Ellis
- Korein Tillery
- Lowey Dannenberg
- Marcus & Shapira
- McCarter & English
- Milbank LLP
- Miller Shah LLP
- Mintz Levin
- Morrison Foerster
- Nussbaum Law Group
- Radice Law Firm
- Schnader Harrison
- Scott&Scott
- Shapiro Haber
- Shapiro & Teitelbaum
- Smith Segura Raphael & Leger
- Taus Cebulash
- Venable LLP
- Wexler Boley
- Wilentz Goldman
- Williams & Connolly
- Windels Marx
Companies
- AstraZeneca PLC
- Cardinal Health Inc.
- Careplus Health Plans Inc.
- CVS Health Corp.
- Dr. Reddy's Laboratories Ltd.
- Express Scripts Holding Co.
- Fraternal Order of Police
- Giant Eagle Inc.
- H‑E‑B LP
- Humana Inc.
- McKesson Corp.
- Ranbaxy
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Safeway Inc.
- Supervalu Inc.
- Teva Pharmaceutical Industries Ltd.
- The Kroger Co.
Sectors & Industries:
-
November 20, 2014
AstraZeneca Seeks Judgment In Nexium Pay-For-Delay Case
Coming on the heels of a mistrial bid, Ranbaxy Inc. and AstraZeneca PLC moved for judgment Thursday in a pay-for-delay case unfolding in Massachusetts federal court over the heartburn drug Nexium, arguing no reasonable jury could find the companies schemed to delay a generic version of the drug.
-
November 19, 2014
Ranbaxy Seeks Mistrial In Nexium Pay-For-Delay Case
Ranbaxy Laboratories Ltd. moved for a mistrial Wednesday in a pay-for-delay case in Massachusetts federal court over the heartburn treatment Nexium, arguing the court's shifting stance on the nature of the generic producer's antitrust liability in the case has prejudiced the company.
-
November 10, 2014
Drug Cos. Seek Judgment In Nexium Pay-For-Delay Case
AstraZeneca PLC and two generic-drug makers asked a Massachusetts federal court on Monday for judgment on all claims in a pay-for-delay case over the heartburn treatment Nexium, arguing that the plaintiffs hadn't shown that a $9 million deal in a separate patent suit constituted a large, unjustified payment.
-
November 05, 2014
Nexium Buyers Seek Litigation Docs From AstraZeneca
Nexium buyers in a pay-for-delay case against AstraZeneca PLC and two generic-drug makers on Wednesday asked a Massachusetts federal judge to order AstraZeneca to hand over key litigation and settlement documents for trial, saying the company is using privilege as a "sword and a shield."
-
October 22, 2014
Nexium Jury Hears From Walgreen Exec On Generics
A Walgreen Co. executive testified Wednesday at a pay-for-delay trial over AstraZeneca PLC's Nexium that the heartburn treatment did face competition for prescriptions from several other similar drugs, but emphasized that cheaper generic versions were only available for a few lower dosages.
-
October 21, 2014
Nexium Jury Told Drug Cos. Wheeled-And-Dealed With Patent
Nexium buyers pursuing a pay-for-delay case against AstraZeneca PLC and two generic-drug makers told a Boston federal jury on Tuesday that the pharmaceutical companies were trying to game the patent system to overcharge consumers by billions of dollars for the heartburn treatment.
-
October 21, 2014
Nexium Pay-For-Delay Jury Told Size Of Settlement Is Key
As the first pay-for-delay jury trial kicked off Tuesday, a Boston federal judge told jurors that though patent settlements are usually good, a large and unexplained payment in the case over Nexium could spell trouble under antitrust law.
-
October 20, 2014
Dr. Reddy's Settles On Eve Of Nexium Pay-For-Delay Trial
Dr. Reddy's Laboratories Ltd. agreed Sunday to help drug buyers make their pay-for-delay case against AstraZeneca PLC and two generic-drug makers as part of a settlement inked on the eve of trial in the antitrust class action.
-
October 09, 2014
Covington Atty Beats Back Trial Subpoena In Nexium MDL
A Covington & Burling LLP partner does not have to offer live testimony in the upcoming pay-for-delay trial in multidistrict litigation against AstraZeneca PLC over the heartburn drug Nexium, a Massachusetts federal judge ruled Thursday, ending a contentious dispute over whether a prerecorded deposition should suffice.
-
October 06, 2014
Covington Atty Says No Basis For Nexium Trial Subpoena
A Covington & Burling LLP partner said Monday that the plaintiffs' subpoena, in an upcoming pay-for-delay trial in multidistrict litigation against AstraZeneca PLC over the heartburn drug Nexium, forcing him to offer live testimony via video feed amounts to a "reckless attack" on his reputation.